APO Research
Talk to an analyst

APO RESEARCH · REPORT

Maternal Pertussis Vaccine for Newborn Protection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Maternal Pertussis Vaccine for Newborn Protection Market Analysis and Forecast 2026-2032

27 December 2025196 pages

Choose your research edition.

Industry ResearchMaternal Pertussis Vaccine for Newborn Protection Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Maternal Pertussis Vaccine for Newborn Protection Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Maternal Pertussis Vaccine for Newborn Protection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Maternal Pertussis Vaccine for Newborn Protection Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Maternal Pertussis Vaccine for Newborn Protection Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Maternal Pertussis Vaccine for Newborn Protection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Maternal Pertussis Vaccine for Newborn Protection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Maternal Pertussis Vaccine for Newborn Protection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Maternal Pertussis Vaccine for Newborn Protection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Maternal Pertussis Vaccine for Newborn Protection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Maternal Pertussis Vaccine for Newborn Protection include Zhifei Biological, Walvax, Minhai Biological, GlaxoSmithKline, Sanofi Pasteur and Intravacc, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Maternal Pertussis Vaccine for Newborn Protection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Maternal Pertussis Vaccine for Newborn Protection, also provides the sales of main regions and countries. Of the upcoming market potential for Maternal Pertussis Vaccine for Newborn Protection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Maternal Pertussis Vaccine for Newborn Protection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Maternal Pertussis Vaccine for Newborn Protection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Maternal Pertussis Vaccine for Newborn Protection sales, projected growth trends, production technology, application and end-user industry.

Maternal Pertussis Vaccine for Newborn Protection Segment by Company

Zhifei Biological

Walvax

Minhai Biological

GlaxoSmithKline

Sanofi Pasteur

Intravacc

Maternal Pertussis Vaccine for Newborn Protection Segment by Type

Whole-cell Pertussis Vaccine

Acellular Pertussis Vaccine

Maternal Pertussis Vaccine for Newborn Protection Segment by Application

Hospital

Centers for Disease Control and Prevention

Others

Maternal Pertussis Vaccine for Newborn Protection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Maternal Pertussis Vaccine for Newborn Protection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Maternal Pertussis Vaccine for Newborn Protection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Maternal Pertussis Vaccine for Newborn Protection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Maternal Pertussis Vaccine for Newborn Protection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Maternal Pertussis Vaccine for Newborn Protection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Maternal Pertussis Vaccine for Newborn Protection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Maternal Pertussis Vaccine for Newborn Protection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Whole-cell Pertussis Vaccine Major Manufacturers Table 3. Acellular Pertussis Vaccine Major Manufacturers Table 4. Global Maternal Pertussis Vaccine for Newborn Protection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Centers for Disease Control and Prevention Major Manufacturers Table 7. Others Major Manufacturers Table 8. Maternal Pertussis Vaccine for Newborn Protection Industry Trends Table 9. Maternal Pertussis Vaccine for Newborn Protection Industry Drivers Table 10. Maternal Pertussis Vaccine for Newborn Protection Industry Opportunities and Challenges Table 11. Maternal Pertussis Vaccine for Newborn Protection Industry Restraints Table 12. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Region (2021-2026) Table 16. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Region (2027-2032) Table 17. Global Maternal Pertussis Vaccine for Newborn Protection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Units) Table 18. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region (2021-2026) & (Units) Table 19. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region (2027-2032) & (Units) Table 20. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Region (2021-2026) Table 21. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Region (2027-2032) Table 22. Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Manufacturers (2021-2026) Table 26. Global Maternal Pertussis Vaccine for Newborn Protection Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Maternal Pertussis Vaccine for Newborn Protection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Maternal Pertussis Vaccine for Newborn Protection Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Maternal Pertussis Vaccine for Newborn Protection Manufacturers, Product Type & Application Table 30. Global Maternal Pertussis Vaccine for Newborn Protection Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Maternal Pertussis Vaccine for Newborn Protection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Type (2021-2026) Table 37. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Type (2027-2032) Table 38. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Type 2021 VS 2025 VS 2032 (Units) Table 39. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2026) & (Units) Table 40. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2027-2032) & (Units) Table 41. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Type (2021-2026) Table 42. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Type (2027-2032) Table 43. Global Maternal Pertussis Vaccine for Newborn Protection Price by Type (2021-2026) & (US$/Unit) Table 44. Global Maternal Pertussis Vaccine for Newborn Protection Price by Type (2027-2032) & (US$/Unit) Table 45. Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Application (2021-2026) Table 49. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Application (2027-2032) Table 50. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Application 2021 VS 2025 VS 2032 (Units) Table 51. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2026) & (Units) Table 52. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2027-2032) & (Units) Table 53. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Application (2021-2026) Table 54. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Application (2027-2032) Table 55. Global Maternal Pertussis Vaccine for Newborn Protection Price by Application (2021-2026) & (US$/Unit) Table 56. Global Maternal Pertussis Vaccine for Newborn Protection Price by Application (2027-2032) & (US$/Unit) Table 57. Zhifei Biological Company Information Table 58. Zhifei Biological Business Overview Table 59. Zhifei Biological Maternal Pertussis Vaccine for Newborn Protection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Zhifei Biological Maternal Pertussis Vaccine for Newborn Protection Product Portfolio Table 61. Zhifei Biological Recent Development Table 62. Walvax Company Information Table 63. Walvax Business Overview Table 64. Walvax Maternal Pertussis Vaccine for Newborn Protection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Walvax Maternal Pertussis Vaccine for Newborn Protection Product Portfolio Table 66. Walvax Recent Development Table 67. Minhai Biological Company Information Table 68. Minhai Biological Business Overview Table 69. Minhai Biological Maternal Pertussis Vaccine for Newborn Protection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Minhai Biological Maternal Pertussis Vaccine for Newborn Protection Product Portfolio Table 71. Minhai Biological Recent Development Table 72. GlaxoSmithKline Company Information Table 73. GlaxoSmithKline Business Overview Table 74. GlaxoSmithKline Maternal Pertussis Vaccine for Newborn Protection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. GlaxoSmithKline Maternal Pertussis Vaccine for Newborn Protection Product Portfolio Table 76. GlaxoSmithKline Recent Development Table 77. Sanofi Pasteur Company Information Table 78. Sanofi Pasteur Business Overview Table 79. Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Product Portfolio Table 81. Sanofi Pasteur Recent Development Table 82. Intravacc Company Information Table 83. Intravacc Business Overview Table 84. Intravacc Maternal Pertussis Vaccine for Newborn Protection Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Intravacc Maternal Pertussis Vaccine for Newborn Protection Product Portfolio Table 86. Intravacc Recent Development Table 87. North America Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2021-2026) & (US$ Million) Table 88. North America Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2027-2032) & (US$ Million) Table 89. North America Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2026) & (Units) Table 90. North America Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2027-2032) & (Units) Table 91. North America Maternal Pertussis Vaccine for Newborn Protection Sales Price by Type (2021-2026) & (US$/Unit) Table 92. North America Maternal Pertussis Vaccine for Newborn Protection Sales Price by Type (2027-2032) & (US$/Unit) Table 93. North America Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2021-2026) & (US$ Million) Table 94. North America Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2027-2032) & (US$ Million) Table 95. North America Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2026) & (Units) Table 96. North America Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2027-2032) & (Units) Table 97. North America Maternal Pertussis Vaccine for Newborn Protection Sales Price by Application (2021-2026) & (US$/Unit) Table 98. North America Maternal Pertussis Vaccine for Newborn Protection Sales Price by Application (2027-2032) & (US$/Unit) Table 99. North America Maternal Pertussis Vaccine for Newborn Protection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. North America Maternal Pertussis Vaccine for Newborn Protection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 101. North America Maternal Pertussis Vaccine for Newborn Protection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 102. North America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 103. North America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021-2026) & (Units) Table 104. North America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2027-2032) & (Units) Table 105. North America Maternal Pertussis Vaccine for Newborn Protection Sales Price by Country (2021-2026) & (US$/Unit) Table 106. North America Maternal Pertussis Vaccine for Newborn Protection Sales Price by Country (2027-2032) & (US$/Unit) Table 107. United States Maternal Pertussis Vaccine for Newborn Protection Revenue (2021-2032) & (US$ Million) Table 108. Canada Maternal Pertussis Vaccine for Newborn Protection Revenue (2021-2032) & (US$ Million) Table 109. Mexico Maternal Pertussis Vaccine for Newborn Protection Revenue (2021-2032) & (US$ Million) Table 110. Europe Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2021-2026) & (US$ Million) Table 111. Europe Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2027-2032) & (US$ Million) Table 112. Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2026) & (Units) Table 113. Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2027-2032) & (Units) Table 114. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Price by Type (2021-2026) & (US$/Unit) Table 115. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Price by Type (2027-2032) & (US$/Unit) Table 116. Europe Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2021-2026) & (US$ Million) Table 117. Europe Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2027-2032) & (US$ Million) Table 118. Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2026) & (Units) Table 119. Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2027-2032) & (Units) Table 120. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Price by Application (2021-2026) & (US$/Unit) Table 121. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Price by Application (2027-2032) & (US$/Unit) Table 122. Europe Maternal Pertussis Vaccine for Newborn Protection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe Maternal Pertussis Vaccine for Newborn Protection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 124. Europe Maternal Pertussis Vaccine for Newborn Protection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 125. Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 126. Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021-2026) & (Units) Table 127. Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2027-2032) & (Units) Table 128. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Price by Country (2021-2026) & (US$/Unit) Table 129. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Price by Country (2027-2032) & (US$/Unit) Table 130. Germany Maternal Pertussis Vaccine for Newborn Protection Revenue (2021-2032) & (US$ Million) Table 131. France Maternal Pertussis Vaccine for Newborn Protection Revenue (2021-2032) & (US$ Million) Table 132. U.K. Maternal Pertussis Vaccine for Newborn Protection Revenue (2021-2032) & (US$ Million) Table 133. Italy Maternal Pertussis Vaccine for Newborn Protection Revenue (2021-2032) & (US$ Million) Table 134. Russia Maternal Pertussis Vaccine for Newborn Protection Revenue (2021-2032) & (US$ Million) Table 135. Spain Maternal Pertussis Vaccine for Newborn Protection Revenue (2021-2032) & (US$ Million) Table 136. Netherlands Maternal Pertussis Vaccine for Newborn Protection Revenue (2021-2032) & (US$ Million) Table 137. Switzerland Maternal Pertussis Vaccine for Newborn Protection Revenue (2021-2032) & (US$ Million) Table 138. Sweden Maternal Pertussis Vaccine for Newborn Protection Revenue (2021-2032) & (US$ Million) Table 139. Poland Maternal Pertussis Vaccine for Newborn Protection Revenue (2021-2032) & (US$ Million) Table 140. China Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2021-2026) & (US$ Million) Table 141. China Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2027-2032) & (US$ Million) Table 142. China Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2026) & (Units) Table 143. China Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2027-2032) & (Units) Table 144. China Maternal Pertussis Vaccine for Newborn Protection Sales Price by Type (2021-2026) & (US$/Unit) Table 145. China Maternal Pertussis Vaccine for Newborn Protection Sales Price by Type (2027-2032) & (US$/Unit) Table 146. China Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2021-2026) & (US$ Million) Table 147. China Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2027-2032) & (US$ Million) Table 148. China Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2026) & (Units) Table 149. China Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2027-2032) & (Units) Table 150. China Maternal Pertussis Vaccine for Newborn Protection Sales Price by Application (2021-2026) & (US$/Unit) Table 151. China Maternal Pertussis Vaccine for Newborn Protection Sales Price by Application (2027-2032) & (US$/Unit) Table 152. Asia Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2021-2026) & (US$ Million) Table 153. Asia Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2027-2032) & (US$ Million) Table 154. Asia Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2026) & (Units) Table 155. Asia Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2027-2032) & (Units) Table 156. Asia Maternal Pertussis Vaccine for Newborn Protection Sales Price by Type (2021-2026) & (US$/Unit) Table 157. Asia Maternal Pertussis Vaccine for Newborn Protection Sales Price by Type (2027-2032) & (US$/Unit) Table 158. Asia Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2021-2026) & (US$ Million) Table 159. Asia Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2027-2032) & (US$ Million) Table 160. Asia Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2026) & (Units) Table 161. Asia Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2027-2032) & (Units) Table 162. Asia Maternal Pertussis Vaccine for Newborn Protection Sales Price by Application (2021-2026) & (US$/Unit) Table 163. Asia Maternal Pertussis Vaccine for Newborn Protection Sales Price by Application (2027-2032) & (US$/Unit) Table 164. Asia Maternal Pertussis Vaccine for Newborn Protection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. Asia Maternal Pertussis Vaccine for Newborn Protection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 166. Asia Maternal Pertussis Vaccine for Newborn Protection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 167. Asia Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 168. Asia Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021-2026) & (Units) Table 169. Asia Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2027-2032) & (Units) Table 170. Asia Maternal Pertussis Vaccine for Newborn Protection Sales Price by Country (2021-2026) & (US$/Unit) Table 171. Asia Maternal Pertussis Vaccine for Newborn Protection Sales Price by Country (2027-2032) & (US$/Unit) Table 172. Japan Maternal Pertussis Vaccine for Newborn Protection Revenue (2021-2032) & (US$ Million) Table 173. South Korea Maternal Pertussis Vaccine for Newborn Protection Revenue (2021-2032) & (US$ Million) Table 174. India Maternal Pertussis Vaccine for Newborn Protection Revenue (2021-2032) & (US$ Million) Table 175. Australia Maternal Pertussis Vaccine for Newborn Protection Revenue (2021-2032) & (US$ Million) Table 176. Taiwan Maternal Pertussis Vaccine for Newborn Protection Revenue (2021-2032) & (US$ Million) Table 177. Southeast Asia Maternal Pertussis Vaccine for Newborn Protection Revenue (2021-2032) & (US$ Million) Table 178. SAMEA Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2021-2026) & (US$ Million) Table 179. SAMEA Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2027-2032) & (US$ Million) Table 180. SAMEA Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2026) & (Units) Table 181. SAMEA Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2027-2032) & (Units) Table 182. SAMEA Maternal Pertussis Vaccine for Newborn Protection Sales Price by Type (2021-2026) & (US$/Unit) Table 183. SAMEA Maternal Pertussis Vaccine for Newborn Protection Sales Price by Type (2027-2032) & (US$/Unit) Table 184. SAMEA Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2021-2026) & (US$ Million) Table 185. SAMEA Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2027-2032) & (US$ Million) Table 186. SAMEA Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2026) & (Units) Table 187. SAMEA Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2027-2032) & (Units) Table 188. SAMEA Maternal Pertussis Vaccine for Newborn Protection Sales Price by Application (2021-2026) & (US$/Unit) Table 189. SAMEA Maternal Pertussis Vaccine for Newborn Protection Sales Price by Application (2027-2032) & (US$/Unit) Table 190. SAMEA Maternal Pertussis Vaccine for Newborn Protection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 191. SAMEA Maternal Pertussis Vaccine for Newborn Protection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 192. SAMEA Maternal Pertussis Vaccine for Newborn Protection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 193. SAMEA Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 194. SAMEA Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021-2026) & (Units) Table 195. SAMEA Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2027-2032) & (Units) Table 196. SAMEA Maternal Pertussis Vaccine for Newborn Protection Sales Price by Country (2021-2026) & (US$/Unit) Table 197. SAMEA Maternal Pertussis Vaccine for Newborn Protection Sales Price by Country (2027-2032) & (US$/Unit) Table 198. Brazil Maternal Pertussis Vaccine for Newborn Protection Revenue (2021-2032) & (US$ Million) Table 199. Argentina Maternal Pertussis Vaccine for Newborn Protection Revenue (2021-2032) & (US$ Million) Table 200. Chile Maternal Pertussis Vaccine for Newborn Protection Revenue (2021-2032) & (US$ Million) Table 201. Colombia Maternal Pertussis Vaccine for Newborn Protection Revenue (2021-2032) & (US$ Million) Table 202. Peru Maternal Pertussis Vaccine for Newborn Protection Revenue (2021-2032) & (US$ Million) Table 203. Saudi Arabia Maternal Pertussis Vaccine for Newborn Protection Revenue (2021-2032) & (US$ Million) Table 204. Israel Maternal Pertussis Vaccine for Newborn Protection Revenue (2021-2032) & (US$ Million) Table 205. UAE Maternal Pertussis Vaccine for Newborn Protection Revenue (2021-2032) & (US$ Million) Table 206. Turkey Maternal Pertussis Vaccine for Newborn Protection Revenue (2021-2032) & (US$ Million) Table 207. Iran Maternal Pertussis Vaccine for Newborn Protection Revenue (2021-2032) & (US$ Million) Table 208. Egypt Maternal Pertussis Vaccine for Newborn Protection Revenue (2021-2032) & (US$ Million) Table 209. Key Raw Materials Table 210. Raw Materials Key Suppliers Table 211. Maternal Pertussis Vaccine for Newborn Protection Distributors List Table 212. Maternal Pertussis Vaccine for Newborn Protection Customers List Table 213. Research Programs/Design for This Report Table 214. Authors List of This Report Table 215. Secondary Sources Table 216. Primary Sources List of Figures Figure 1. Maternal Pertussis Vaccine for Newborn Protection Image Figure 2. Global Maternal Pertussis Vaccine for Newborn Protection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Maternal Pertussis Vaccine for Newborn Protection Market Size Share 2021 VS 2025 VS 2032 Figure 4. Whole-cell Pertussis Vaccine Image Figure 5. Acellular Pertussis Vaccine Image Figure 6. Global Maternal Pertussis Vaccine for Newborn Protection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Maternal Pertussis Vaccine for Newborn Protection Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Centers for Disease Control and Prevention Image Figure 10. Others Image Figure 11. Global Maternal Pertussis Vaccine for Newborn Protection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Maternal Pertussis Vaccine for Newborn Protection Revenue (2021-2032) & (US$ Million) Figure 13. Global Maternal Pertussis Vaccine for Newborn Protection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Region (2021-2032) Figure 16. Global Maternal Pertussis Vaccine for Newborn Protection Sales (2021-2032) & (Units) Figure 17. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 18. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Maternal Pertussis Vaccine for Newborn Protection Sales YoY (2021-2032) & (Units) Figure 20. Europe Maternal Pertussis Vaccine for Newborn Protection Sales YoY (2021-2032) & (Units) Figure 21. China Maternal Pertussis Vaccine for Newborn Protection Sales YoY (2021-2032) & (Units) Figure 22. Asia (Excluding China) Maternal Pertussis Vaccine for Newborn Protection Sales YoY (2021-2032) & (Units) Figure 23. South America, Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales YoY (2021-2032) & (Units) Figure 24. Global Maternal Pertussis Vaccine for Newborn Protection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Maternal Pertussis Vaccine for Newborn Protection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Type (2021-2032) Figure 30. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021 VS 2025 VS 2032) & (Units) Figure 31. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Type (2021-2032) Figure 33. Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Application (2021-2032) Figure 36. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021 VS 2025 VS 2032) & (Units) Figure 37. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Application (2021-2032) Figure 39. North America Maternal Pertussis Vaccine for Newborn Protection Revenue Share by Type (2021-2032) Figure 40. North America Maternal Pertussis Vaccine for Newborn Protection Sales Share by Type (2021-2032) Figure 41. North America Maternal Pertussis Vaccine for Newborn Protection Revenue Share by Application (2021-2032) Figure 42. North America Maternal Pertussis Vaccine for Newborn Protection Sales Share by Application (2021-2032) Figure 43. North America Maternal Pertussis Vaccine for Newborn Protection Revenue Share by Country (2021-2032) Figure 44. North America Maternal Pertussis Vaccine for Newborn Protection Sales Share by Country (2021-2032) Figure 45. Europe Maternal Pertussis Vaccine for Newborn Protection Revenue Share by Type (2021-2032) Figure 46. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Share by Type (2021-2032) Figure 47. Europe Maternal Pertussis Vaccine for Newborn Protection Revenue Share by Application (2021-2032) Figure 48. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Share by Application (2021-2032) Figure 49. Europe Maternal Pertussis Vaccine for Newborn Protection Revenue Share by Country (2021-2032) Figure 50. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Share by Country (2021-2032) Figure 51. China Maternal Pertussis Vaccine for Newborn Protection Revenue Share by Type (2021-2032) Figure 52. China Maternal Pertussis Vaccine for Newborn Protection Sales Share by Type (2021-2032) Figure 53. China Maternal Pertussis Vaccine for Newborn Protection Revenue Share by Application (2021-2032) Figure 54. China Maternal Pertussis Vaccine for Newborn Protection Sales Share by Application (2021-2032) Figure 55. Asia Maternal Pertussis Vaccine for Newborn Protection Revenue Share by Type (2021-2032) Figure 56. Asia Maternal Pertussis Vaccine for Newborn Protection Sales Share by Type (2021-2032) Figure 57. Asia Maternal Pertussis Vaccine for Newborn Protection Revenue Share by Application (2021-2032) Figure 58. Asia Maternal Pertussis Vaccine for Newborn Protection Sales Share by Application (2021-2032) Figure 59. Asia Maternal Pertussis Vaccine for Newborn Protection Revenue Share by Country (2021-2032) Figure 60. Asia Maternal Pertussis Vaccine for Newborn Protection Sales Share by Country (2021-2032) Figure 61. SAMEA Maternal Pertussis Vaccine for Newborn Protection Revenue Share by Type (2021-2032) Figure 62. SAMEA Maternal Pertussis Vaccine for Newborn Protection Sales Share by Type (2021-2032) Figure 63. SAMEA Maternal Pertussis Vaccine for Newborn Protection Revenue Share by Application (2021-2032) Figure 64. SAMEA Maternal Pertussis Vaccine for Newborn Protection Sales Share by Application (2021-2032) Figure 65. SAMEA Maternal Pertussis Vaccine for Newborn Protection Revenue Share by Country (2021-2032) Figure 66. SAMEA Maternal Pertussis Vaccine for Newborn Protection Sales Share by Country (2021-2032) Figure 67. Maternal Pertussis Vaccine for Newborn Protection Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Maternal Pertussis Vaccine for Newborn Protection Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Whole-cell Pertussis Vaccine
  • Acellular Pertussis Vaccine
Applications
  • Hospital
  • Centers for Disease Control and Prevention
  • Others
Companies covered
  • Zhifei Biological
  • Walvax
  • Minhai Biological
  • GlaxoSmithKline
  • Sanofi Pasteur
  • Intravacc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Maternal Pertussis Vaccine for Newborn Protection Market by Type
  3. 1.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Whole-cell Pertussis Vaccine
  5. 1.2.3 Acellular Pertussis Vaccine
  6. 1.3 Maternal Pertussis Vaccine for Newborn Protection Market by Application
  7. 1.3.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Centers for Disease Control and Prevention
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Maternal Pertussis Vaccine for Newborn Protection Market Dynamics
  1. 2.1 Maternal Pertussis Vaccine for Newborn Protection Industry Trends
  2. 2.2 Maternal Pertussis Vaccine for Newborn Protection Industry Drivers
  3. 2.3 Maternal Pertussis Vaccine for Newborn Protection Industry Opportunities and Challenges
  4. 2.4 Maternal Pertussis Vaccine for Newborn Protection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Maternal Pertussis Vaccine for Newborn Protection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Region
  3. 3.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Region (2021-2026)
  5. 3.2.3 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Region (2027-2032)
  6. 3.2.4 Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Maternal Pertussis Vaccine for Newborn Protection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region
  9. 3.4.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region (2021-2026)
  11. 3.4.3 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region (2027-2032)
  12. 3.4.4 Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Manufacturers
  2. 4.1.1 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Maternal Pertussis Vaccine for Newborn Protection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Manufacturers
  6. 4.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Maternal Pertussis Vaccine for Newborn Protection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Maternal Pertussis Vaccine for Newborn Protection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Maternal Pertussis Vaccine for Newborn Protection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Maternal Pertussis Vaccine for Newborn Protection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Maternal Pertussis Vaccine for Newborn Protection Manufacturers, Product Type & Application
  13. 4.7 Global Maternal Pertussis Vaccine for Newborn Protection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Maternal Pertussis Vaccine for Newborn Protection Market CR5 and HHI
  16. 4.8.2 2025 Maternal Pertussis Vaccine for Newborn Protection Tier 1, Tier 2, and Tier 3
5 Maternal Pertussis Vaccine for Newborn Protection Market by Type
  1. 5.1 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Type
  2. 5.1.1 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Type
  6. 5.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2032) & (Units)
  8. 5.2.3 Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Maternal Pertussis Vaccine for Newborn Protection Price by Type
6 Maternal Pertussis Vaccine for Newborn Protection Market by Application
  1. 6.1 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Application
  2. 6.1.1 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Application
  6. 6.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2032) & (Units)
  8. 6.2.3 Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Maternal Pertussis Vaccine for Newborn Protection Price by Application
7 Company Profiles
  1. 7.1 Zhifei Biological
  2. 7.1.1 Zhifei Biological Company Information
  3. 7.1.2 Zhifei Biological Business Overview
  4. 7.1.3 Zhifei Biological Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Zhifei Biological Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
  6. 7.1.5 Zhifei Biological Recent Developments
  7. 7.2 Walvax
  8. 7.2.1 Walvax Company Information
  9. 7.2.2 Walvax Business Overview
  10. 7.2.3 Walvax Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Walvax Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
  12. 7.2.5 Walvax Recent Developments
  13. 7.3 Minhai Biological
  14. 7.3.1 Minhai Biological Company Information
  15. 7.3.2 Minhai Biological Business Overview
  16. 7.3.3 Minhai Biological Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Minhai Biological Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
  18. 7.3.5 Minhai Biological Recent Developments
  19. 7.4 GlaxoSmithKline
  20. 7.4.1 GlaxoSmithKline Company Information
  21. 7.4.2 GlaxoSmithKline Business Overview
  22. 7.4.3 GlaxoSmithKline Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 GlaxoSmithKline Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
  24. 7.4.5 GlaxoSmithKline Recent Developments
  25. 7.5 Sanofi Pasteur
  26. 7.5.1 Sanofi Pasteur Company Information
  27. 7.5.2 Sanofi Pasteur Business Overview
  28. 7.5.3 Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
  30. 7.5.5 Sanofi Pasteur Recent Developments
  31. 7.6 Intravacc
  32. 7.6.1 Intravacc Company Information
  33. 7.6.2 Intravacc Business Overview
  34. 7.6.3 Intravacc Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Intravacc Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
  36. 7.6.5 Intravacc Recent Developments
8 North America
  1. 8.1 North America Maternal Pertussis Vaccine for Newborn Protection Market Size by Type
  2. 8.1.1 North America Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2021-2032)
  3. 8.1.2 North America Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2032)
  4. 8.1.3 North America Maternal Pertussis Vaccine for Newborn Protection Price by Type (2021-2032)
  5. 8.2 North America Maternal Pertussis Vaccine for Newborn Protection Market Size by Application
  6. 8.2.1 North America Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2021-2032)
  7. 8.2.2 North America Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2032)
  8. 8.2.3 North America Maternal Pertussis Vaccine for Newborn Protection Price by Application (2021-2032)
  9. 8.3 North America Maternal Pertussis Vaccine for Newborn Protection Market Size by Country
  10. 8.3.1 North America Maternal Pertussis Vaccine for Newborn Protection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Maternal Pertussis Vaccine for Newborn Protection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Maternal Pertussis Vaccine for Newborn Protection Market Size by Type
  2. 9.1.1 Europe Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2032)
  4. 9.1.3 Europe Maternal Pertussis Vaccine for Newborn Protection Price by Type (2021-2032)
  5. 9.2 Europe Maternal Pertussis Vaccine for Newborn Protection Market Size by Application
  6. 9.2.1 Europe Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2032)
  8. 9.2.3 Europe Maternal Pertussis Vaccine for Newborn Protection Price by Application (2021-2032)
  9. 9.3 Europe Maternal Pertussis Vaccine for Newborn Protection Market Size by Country
  10. 9.3.1 Europe Maternal Pertussis Vaccine for Newborn Protection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Maternal Pertussis Vaccine for Newborn Protection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Maternal Pertussis Vaccine for Newborn Protection Market Size by Type
  2. 10.1.1 China Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2021-2032)
  3. 10.1.2 China Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2032)
  4. 10.1.3 China Maternal Pertussis Vaccine for Newborn Protection Price by Type (2021-2032)
  5. 10.2 China Maternal Pertussis Vaccine for Newborn Protection Market Size by Application
  6. 10.2.1 China Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2021-2032)
  7. 10.2.2 China Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2032)
  8. 10.2.3 China Maternal Pertussis Vaccine for Newborn Protection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Maternal Pertussis Vaccine for Newborn Protection Market Size by Type
  2. 11.1.1 Asia Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2032)
  4. 11.1.3 Asia Maternal Pertussis Vaccine for Newborn Protection Price by Type (2021-2032)
  5. 11.2 Asia Maternal Pertussis Vaccine for Newborn Protection Market Size by Application
  6. 11.2.1 Asia Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2032)
  8. 11.2.3 Asia Maternal Pertussis Vaccine for Newborn Protection Price by Application (2021-2032)
  9. 11.3 Asia Maternal Pertussis Vaccine for Newborn Protection Market Size by Country
  10. 11.3.1 Asia Maternal Pertussis Vaccine for Newborn Protection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Maternal Pertussis Vaccine for Newborn Protection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Maternal Pertussis Vaccine for Newborn Protection Market Size by Type
  2. 12.1.1 SAMEA Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Maternal Pertussis Vaccine for Newborn Protection Price by Type (2021-2032)
  5. 12.2 SAMEA Maternal Pertussis Vaccine for Newborn Protection Market Size by Application
  6. 12.2.1 SAMEA Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Maternal Pertussis Vaccine for Newborn Protection Price by Application (2021-2032)
  9. 12.3 SAMEA Maternal Pertussis Vaccine for Newborn Protection Market Size by Country
  10. 12.3.1 SAMEA Maternal Pertussis Vaccine for Newborn Protection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Maternal Pertussis Vaccine for Newborn Protection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Maternal Pertussis Vaccine for Newborn Protection Value Chain Analysis
  2. 13.1.1 Maternal Pertussis Vaccine for Newborn Protection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Maternal Pertussis Vaccine for Newborn Protection Production Mode & Process
  6. 13.2 Maternal Pertussis Vaccine for Newborn Protection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Maternal Pertussis Vaccine for Newborn Protection Distributors
  9. 13.2.3 Maternal Pertussis Vaccine for Newborn Protection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst